MT
VRTX icon

Midwest Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Midwest Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Buy
598
+2
+0.3% +$933 ﹤0.01% 530
2025
Q4 		$270K Sell
596
-24
-4% -$10.3K ﹤0.01% 530
2025
Q3 		$243K Buy
620
+49
+9% +$20.5K ﹤0.01% 548
2025
Q2 		$254K Buy
+571
New +$263K ﹤0.01% 547

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Midwest Trust's VRTX Position: Q1 2026 in Review

Midwest Trust increased its Vertex Pharmaceuticals (VRTX) stake by 0.34% in Q1 2026, buying an estimated $933 and bringing the position to 598 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

Midwest Trust first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $270K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Midwest Trust held 598 shares of Vertex Pharmaceuticals worth $267K as of Q1 2026.
  • Midwest Trust bought 2 Vertex Pharmaceuticals shares in Q1 2026, an estimated $933.
  • Vertex Pharmaceuticals made up ﹤0.01% of Midwest Trust's portfolio in Q1 2026, its #530 holding.
  • Midwest Trust first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Midwest Trust's Vertex Pharmaceuticals position peaked at $270K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.